Integrity Advisory Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Buy
19,928
+17,750
+815% +$3.82M 0.52% 37
2026
Q1
$474K Sell
2,178
-562
-21% -$125K 0.06% 150
2025
Q4
$626K Sell
2,740
-485
-15% -$110K 0.09% 116
2025
Q3
$747K Buy
+3,225
New +$657K 0.12% 91

Other funds holding ABBV

Integrity Advisory Solutions's ABBV Position: Q2 2026 in Review

Integrity Advisory Solutions increased its AbbVie (ABBV) stake by 815% in Q2 2026, buying an estimated $3.82M and bringing the position to 19,928 shares worth $5.01M. The position accounts for 0.52% of the portfolio, ranked #37.

Integrity Advisory Solutions first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Integrity Advisory Solutions held 19,928 shares of AbbVie worth $5.01M as of Q2 2026.
  • Integrity Advisory Solutions bought 17,750 AbbVie shares in Q2 2026, an estimated $3.82M.
  • AbbVie made up 0.52% of Integrity Advisory Solutions's portfolio in Q2 2026, its #37 holding.
  • Integrity Advisory Solutions first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Integrity Advisory Solutions's 13F filing for Q2 2026, filed 31 Jul 2026.